Y H Park

Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

Y H Park, M J Park, S H Ji et al. · British Journal of Cancer · 2009 · 175 citations · Full text

Medicine, Oncology, Breast Oncology +16

Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival

Chel Hun Choi, J-J Choi, Y H Park et al. · British Journal of Cancer · 2012 · 50 citations · Full text

Medicine, Molecular Biology, Oncology +17

Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy

Jung Won Yun, Kyung Hwan Kim, Eun‐Suk Kang et al. · British Journal of Cancer · 2011 · 49 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment

Y H Park, Hyun Ah Jung, M K Choi et al. · British Journal of Cancer · 2013 · 47 citations · Full text

Medicine, Oncology, Pathology +17